Australia markets closed

PharmAust Limited (PAA.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2400-0.0100 (-4.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
3,381
2,824
3,381
2,140
3,196
Cost of revenue
314.343
787.539
314.343
225.318
246.157
Gross profit
3,067
2,036
3,067
1,915
2,950
Operating expenses
Research development
758.655
1,032
758.655
554.144
605.351
Selling general and administrative
4,742
4,301
4,742
3,852
4,241
Total operating expenses
5,816
5,737
5,816
4,706
5,121
Operating income or loss
-2,749
-3,701
-2,749
-2,791
-2,171
Interest expense
88.511
81.862
88.511
78.986
118.495
Total other income/expenses net
1,129
-2,510
1,129
1,517
924.229
Income before tax
-1,708
-6,212
-1,708
-1,337
-1,362
Income tax expense
0
0
0
0
0
Income from continuing operations
-1,708
-6,212
-1,708
-1,337
-1,362
Net income
-1,708
-6,212
-1,708
-1,337
-1,362
Net income available to common shareholders
-1,708
-6,212
-1,708
-1,337
-1,362
Basic EPS
-0.02
-0.02
-0.01
-0.00
-0.00
Diluted EPS
-0.02
-0.02
-0.01
-0.00
-0.00
Basic average shares
321,009
321,009
316,885
315,740
296,032
Diluted average shares
321,009
321,009
316,885
315,740
296,032